Accuray Incorporated (ARAY) - Utang jangka dawa marang modal

Lambang korporat lan logo Accuray Incorporated (ARAY)

The financial price action for Accuray Incorporated (ARAY) demonstrates the dynamics of a company whose position is strengthened by patent protection for robotics and complex equipment certification. The environmental profile is based on the safe recycling of electronics, with the metric standing at 4.13. Business stability is ensured by experienced management, which effectively expands the sales geography despite significant costs associated with developing new medical technologies.

Accuray Inc. - Utang jangka dawa marang modal ARAY (periode 04.07.2022 - 29.10.2026)
Produk asli accuray.com

For an investor in Accuray Incorporated (ARAY), this indicator serves as a measure of financial stability during the implementation of its global expansion strategy for radiation therapy systems. By analyzing the ratio of long-term liabilities to equity, you assess the proportion of loans with maturities exceeding one year relative to net assets, which confirms the ability of the experienced management team to effectively finance expansion without a critical increase in the debt load.

Pesaing wigati

Rasio utang jangka dawa marang ekuitas BeiGene Ltd. (ONC)|Utang jangka dawa marang modal HALO|Utang jangka dawa marang modal Revolution Medicines Corp (RVMD)|Utang jangka dawa marang ekuitas Ascentage Pharma Group AAPG|CGON: Rasio utang jangka dawa marang modal|UroGen Pharma - Utang jangka dawa marang modal|Bicara Therapeutics Inc (BCAX) - Rasio utang jangka dawa marang ekuitas|PSNL: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Erasca Oncology (ERAS)|Utang jangka dawa marang ekuitas Delcath Systems, Inc.|YMAB: Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas AURA (Aura Biosciences)|CADL (candeltx.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal SLS (SELLAS Life Sciences Group)|ACTU - Rasio utang jangka dawa marang ekuitas|CTOR: Rasio utang jangka dawa marang ekuitas|HURA - Utang jangka dawa marang modal|Protara Therapeutics, Inc. (TARA) - Utang jangka dawa marang ekuitas|Fate Therapeutics Inc - Koefisien utang jangka dawa marang modal|WHWK (Aadi Bioscience, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal TScan TCRX|Utang jangka dawa marang modal CSBR|Utang jangka dawa marang modal xbiotech.com (XBIT)|Utang jangka dawa marang modal CVM (CEL-SCI)|OSTX - Rasio utang jangka dawa marang ekuitas|Radiopharm Theranostics Limited - Utang jangka dawa marang modal|Artiva Biotherapeutics, Inc. (ARTV) - Rasio utang jangka dawa marang ekuitas|ANL (adlainortye.com) - Rasio utang jangka dawa marang ekuitas|verupharma.com (VERU) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Tempest Therapeutics, Inc.|XLO: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal RENB|Utang jangka dawa marang modal muraloncology.com (MURA)|Kairos Pharma - Rasio utang jangka dawa marang ekuitas|OnKure Therapeutics, Inc. (OKUR) - Kewajiban jangka dawa marang modal|GDTC: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRIS (Curis, Inc.)|APLM: Utang jangka dawa marang modal|THAR - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Advanced Biomed Inc.|Rasio utang jangka dawa marang modal GNPX (genprex.com)|Utang jangka dawa marang modal CLDI|Rasio utang jangka dawa marang ekuitas Sunshine Biopharma Inc. SBFM|Utang jangka dawa marang ekuitas Xenetic Biosciences, Inc. XBIO|Salarius Pharma (SLRX) - Kewajiban jangka dawa marang modal|PPBT - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal AONC (American Oncology Network)|BeiGene (BGNE) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas CKPT (Checkpoint Therapeutics Inc.)|Utang jangka dawa marang ekuitas Elevation Oncology, Inc.|Kewajiban jangka dawa marang modal iCAD Corp ICAD|Utang jangka dawa marang ekuitas Ikena Oncology, Inc. (IKNA)|NTBL (notablelabs.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal VIRX (Viracta Therapeutics, Inc.)|Utang jangka dawa marang modal MorphoSys Inc MOR|NAYA: Rasio utang jangka dawa marang ekuitas|Ascentage - Rasio silihan jangka dawa marang modal